REBAUDIOSIDE B(P)(NEW)

CAS No. 58543-17-2

REBAUDIOSIDE B(P)(NEW)( —— )

Catalog No. M20471 CAS No. 58543-17-2

REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 86 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    REBAUDIOSIDE B(P)(NEW)
  • Note
    Research use only, not for human use.
  • Brief Description
    REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.
  • Description
    REBAUDIOSIDE B tastes about 150 times sweeter than sucrose and it is non-caloric.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    58543-17-2
  • Formula Weight
    804.87
  • Molecular Formula
    C38H60O18
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (124.24 mM)
  • SMILES
    [H][C@@]12CC[C@@]3(C[C@]1(CC3=C)CC[C@]1([H])[C@@](C)(CCC[C@@]21C)C(O)=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H]1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.In vitro metabolism of rebaudioside E under anaerobic conditions: Comparison with rebaudioside A[J]. Regulatory Toxicology and Pharmacology 2015 72(3):646-657.
molnova catalog
related products
  • Fenoxycarb

    Fenoxycarb is an insecticide against mosquitoes.

  • VH032-cyclopropane-F

    VH032-cyclopropane-F is a VH032-based VHL ligand. VH032-cyclopropane-F can be connected to the ligand for protein by a linker to form PROTACs. PROTAC 1 is a partial degrader of SMARCA2 and SMARCA4.

  • 5-(5-methyl-1H-1,2,4...

    5-(5-methyl-1H-1,2,4-triazol-3-yl)-3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazole can be used in the synthesis of heterocyclic compounds to inhibit HIF pathway activity.